Other Clinical Trial - Study on the Quality of Life Among Adolescents With

Status Completed

Clinical Trial Summary

Attention Deficit Hyperactivity Disorder (ADHD) with a overall prevalence of 5.3% is one of the most common neurobehavioral disorders in children. In the foreign literature, many studies bring to light in children and adolescents the negative impact of ADHD on overall quality of life. Some of these studies were able to identify the fact that the higher the age of ADHD children or adolescents, the lower the quality of life. Currently, to our knowledge, only a few European studies have demonstrated the negative impact of ADHD on the quality of life of children and adolescents. In addition, these studies used only questionnaires intended for parents and not for children or adolescents. During a regular follow-up consultation with their referent child psychiatrist, adolescents accompanied by at least one of their parents will be informed of the modalities of our study. A newsletter will be delivered to parents and one to the adolescent. If neither the adolescent nor the parents is opposed to participate, the child psychiatrist will register the patient on the list of study participants. He will also fill out a medico-social information sheet about the adolescent as to summarize the data in the medical record. At the end of this consultation, in the waiting room, adolescents will answer questionnaires KIDSCREEN-27 and MSPSS; their parents will complete the CBCL questionnaire. These questionnaires will be handed to the secretary who will put them back in the patient's record. The KIDSCREEN-27, MSPSS and CBCL questionnaires as well as the medico-social information sheet will be source documents. The principal investigator or one of the associates investigators will complete the case report form from these source documents. For this purpose the data will be entered anonymously into a data entry software on a computer server secured by the Centre Psychothérapique de Nancy (CPN). Then, anonymous data from the software will be forwarded to Dr. Epstein of the Clinical Investigation Center for statistical analysis. The study will begin when the favourable opinion of the Ethical Research Comittees will be obtained and the study will last one year.

Clinical Trial Description

Cross-sectional, descriptive epidemiological study based on single-centre trials ;

Study Design

Related Conditions & MeSH terms

Attention Deficit Disorder with Hyperactivity
Attention Deficit Hyperactivity Disorder
Hyperkinesis

Clinical Trial Details

NCT number	NCT03719950
Study type	Observational
Source	Centre Psychothérapique de Nancy
Contact
Status	Completed
Phase
Start date	January 2, 2019
Completion date	December 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06129396` - Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)	N/A
Completed	`NCT04779333` - Lifestyle Enhancement for ADHD Program 2	N/A
Recruiting	`NCT05935722` - Evaluation of a Home-based Parenting Support Program: Parenting Young Children	N/A
Completed	`NCT03148782` - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase	N/A
Completed	`NCT04832737` - Strength-based Treatment Approach for Adults With ADHD	N/A
Recruiting	`NCT04631042` - Developing Brain, Impulsivity and Compulsivity
Recruiting	`NCT05048043` - Development of a Game-supported Intervention	N/A
Completed	`NCT03337646` - Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism	Phase 4
Not yet recruiting	`NCT06454604` - Virtual Reality Treatment for Emerging Adults With ADHD	Phase 2
Not yet recruiting	`NCT06406309` - Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD	N/A
Not yet recruiting	`NCT06080373` - Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial	N/A
Completed	`NCT02477280` - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance	Phase 4
Completed	`NCT02911194` - a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)	N/A
Completed	`NCT02390791` - New Technologies to Help Manage ADHD	N/A
Completed	`NCT02555150` - A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD	Phase 3
Completed	`NCT02473185` - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest	Phase 4
Completed	`NCT02829970` - Helping College Students With ADHD Lead Healthier Lifestyles	N/A
Completed	`NCT02780102` - Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD	N/A
Recruiting	`NCT04175028` - Neuromodulation of Executive Function in the ADHD Brain	N/A
Recruiting	`NCT04296604` - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study on the Quality of Life Among Adolescents With Attention Deficit/Hyperactivity Disorder — QuaVAT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms